(Q45732207)

15 December 2017

title

Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity (English)

1 reference

15 December 2017

0 references

4

1 reference

15 December 2017

Qizhi Yao

1

1 reference

15 December 2017

Vinh Vuong

series ordinal

2

1 reference

15 December 2017

Min Li

series ordinal

3

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

15 December 2017

number of pages

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

15 December 2017

volume

20

1 reference

15 December 2017

issue

19-20

1 reference

15 December 2017

page(s)

2537-2545

1 reference

Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Cholera toxin adjuvant greatly promotes antigen priming of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Functional and Immunological Characterization of SIV Envelope Glycoprotein Produced in Genetically Engineered Mammalian Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Recombinant Mycobacterium bovis BCG Producing the N-Terminal Half of SIVmac251 Env Antigen Induces Neutralizing Antibodies and Cytotoxic T Lymphocyte Responses in Mice and Guinea Pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

A Cocktail of Mycobacterium bovis BCG Recombinants Expressing the SIV Nef, Env, and Gag Antigens Induces Antibody and Cytotoxic Responses in Mice Vaccinated by Different Mucosal Routes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Human immunodeficiency virus type 1 and mucosal humoral defense

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Mucosal immunity and tolerance: relevance to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Neutralization of SIVmac239/17E in lymphocyte cultures involves virus strain-specific linear and conformational epitopes encoded by different regions of the env gene including the "V3" domain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900160-3

7 January 2021

10.1016/S0264-410X(02)00160-3

Identifiers

DOI

1 reference

15 December 2017

1 reference